Papers

4

Total Citations

49

H-Index

3

About

Andrew Williamson is a head and neck surgeon whose research focuses on advancing transoral robotic surgery (TORS) and optimizing outcomes for patients with oropharyngeal cancer. His major contributions center on two critical areas: the oncologic safety of de-escalated treatment and the functional consequences of salvage surgery. In his highly cited 2023 systematic review and meta-analysis (22 citations), Williamson demonstrated that negative surgical margins following TORS without adjuvant therapy are strongly associated with reduced local recurrence, providing crucial evidence for de-escalation protocols. He has also pioneered the feasibility of free flap reconstruction after salvage robotic resection for recurrent HPV-positive oropharyngeal cancer, a technically demanding procedure that offers hope for patients with limited options. His work extends to quality-of-life outcomes, where his meta-analysis of salvage surgery (10 citations) quantifies the functional toll of these procedures, while his recent investigation into tongue base mucosectomy (2024) uses validated tools to balance diagnostic benefits against surgical risks. Williamson’s research is notable for its rigorous methodology and direct clinical applicability, helping surgeons and patients make evidence-based decisions about treatment intensity and functional preservation.

Research Focus

Key Achievements

3
H-Index
4
Papers
49
Total Citations
12
Avg Citations/Paper
🏆 Most Cited Paper
Transoral robotic surgery without adjuvant therapy: A systematic review and meta-analysis of the association between surgical margins and local recurrence
22 citations · 2023
📈 Most Prolific Year: 2023 (2 Papers)
🤝 Key Collaborators: 11
🏛 Institutions: Institute of Cancer Research, Charing Cross Hospital, Imperial College Healthcare NHS Trust

Top Papers

  1. 1
  2. 2
  3. 3
  4. 4

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago